Targeting CD5 CAR-T Cells in the Treatment of r/r CD5+ T-lymphoma

NCT06633341 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

T-lymphoblastic Lymphoma

Interventions

BIOLOGICAL: CD5 CAR T-cells

Sponsor

Zhejiang University

Collaborators

[object Object]